Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tracking asthma patients on new biologic treatment for 3 years

NCT ID NCT04550962

Ongoing Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study follows asthma patients who are starting treatment with Dupixent in real-world medical settings. Researchers will track 376 patients for up to 3 years to understand how well the medication works, what side effects occur, and how patients use the treatment alongside other asthma medications. The goal is to gather practical information about Dupixent's effectiveness and safety outside of controlled clinical trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 0320001

    Ciudad Autonoma Bs As, C1121ABE, Argentina

  • Investigational Site Number : 0320004

    Santa Fe, 3000, Argentina

  • Investigational Site Number : 0320005

    La Plata, Buenos Aires, B1900BNN, Argentina

  • Investigational Site Number : 0320006

    Villa Rosa, Buenos Aires, 1631, Argentina

  • Investigational Site Number : 0320008

    Ciudad Autonoma Buenos Aires, C1425BEN, Argentina

  • Investigational Site Number : 0320009

    San Miguel de Tucumán, T4000IAI, Argentina

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 7500692, Chile

  • Investigational Site Number : 1520002

    Quillota, Región de Valparaíso, 2260877, Chile

  • Investigational Site Number : 1700003

    Bucaramanga, Colombia

  • Investigational Site Number : 1700004

    Bogotá, Colombia

  • Investigational Site Number : 1700009

    Barranquilla, 080001, Colombia

  • Investigational Site Number : 3760001

    Kfar Saba, 4428164, Israel

  • Investigational Site Number : 3760003

    Jerusalem, 91120, Israel

  • Investigational Site Number : 3760004

    Ashkelon, 78278, Israel

  • Investigational Site Number : 3760005

    Jerusalem, 91031, Israel

  • Investigational Site Number : 3760006

    Rehovot, 7642001, Israel

  • Investigational Site Number : 3760007

    Tel Aviv, 64239, Israel

  • Investigational Site Number : 3760008

    Ashdod, 7747629, Israel

  • Investigational Site Number : 4140001

    Kuwait City, 00000, Kuwait

  • Investigational Site Number : 4220001

    Beirut, Lebanon

  • Investigational Site Number : 4220002

    Beirut, 11 0236, Lebanon

  • Investigational Site Number : 4220003

    El Achrafiyé, Lebanon

  • Investigational Site Number : 4840003

    Durango, 34000, Mexico

  • Investigational Site Number : 6340001

    Doha, Qatar

  • Investigational Site Number : 6430002

    Stavropol, 355020, Russia

  • Investigational Site Number : 6430004

    Moscow, 115522, Russia

  • Investigational Site Number : 6430005

    Chelyabinsk, 454091, Russia

  • Investigational Site Number : 6430006

    Rostov-on-Don, 344012, Russia

  • Investigational Site Number : 6430007

    Moscow, 105077, Russia

  • Investigational Site Number : 6430008

    Saratov, 410012, Russia

  • Investigational Site Number : 6820001

    Riyadh, 12713, Saudi Arabia

  • Investigational Site Number : 6820002

    Riyadh, 11525, Saudi Arabia

  • Investigational Site Number : 6820004

    Mecca, 24246, Saudi Arabia

  • Investigational Site Number : 6820005

    Jeddah, 23433, Saudi Arabia

  • Investigational Site Number : 7020001

    Singapore, 169308, Singapore

  • Investigational Site Number : 7020002

    Singapore, 119074, Singapore

  • Investigational Site Number : 7840001

    Dubai, 4545, United Arab Emirates

  • Investigational Site Number : 7840002

    Sharjah city, 3499, United Arab Emirates

  • Investigational Site Number : 7840004

    Sharjah city, 00000, United Arab Emirates

  • Investigational Site Number : 7840006

    Abu Dhabi, 0000, United Arab Emirates

  • Investigational Site Number : 7840007

    Dubai, 2, United Arab Emirates

Conditions

Explore the condition pages connected to this study.

ASTHMA